|Company Name||Sientra, Inc.|
The Firm is investigating potential claims on behalf of investors of Sientra, Inc. ("Sientra" or the "Company") (NASDAQ:SIEN) concerning the Company’s and its officers’ possible violations of federal securities laws in connection with Sientra’s alleged intentional misleading of investors regarding its compliance with relevant safety and production standards.
On September 23, 2015, the Company announced the closing of a public offering of 3 million shares of common stock. Then on September 24, 2015, the Company disclosed that the U.K.’s Medicines and Healthcare products Regulatory Agency has suspended distribution of its Silimed products. On this news the Company’s shares fell $10.88 per share, or over 52%, to close on September 24, 2015 at $9.70 per share. Investors have been damaged by this alleged disclosure of fraud, and GPM is preparing a lawsuit to recover damages on behalf of Sientra investors.
If you purchased Sientra securities, have information or would like to learn more about these claims including whether you qualify to serve as a class representative, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to email@example.com.
Submit Your Information
If you suffered a loss on your Sientra, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.